Cargando…
The challenges and optimization of cell-based therapy for cardiovascular disease
With the hope of achieving real cardiovascular repair, cell-based therapy raised as a promising strategy for the treatment of cardiovascular disease (CVD) in the past two decades. Various types of cells have been studied for their reparative potential for CVD in the ensuing years. Despite the exciti...
Autores principales: | Xu, Shiyue, Qiu, Yumin, Tao, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802397/ https://www.ncbi.nlm.nih.gov/pubmed/35136722 http://dx.doi.org/10.2478/jtim-2021-0017 |
Ejemplares similares
-
Endothelial progenitor cells in cardiovascular diseases
por: Qiu, Yumin, et al.
Publicado: (2018) -
Opportunities for improving use of evidence‐based therapy in patients with type 2 diabetes and cardiovascular disease
por: Gao, Yumin, et al.
Publicado: (2019) -
Opportunities and challenges in stem cell therapy in cardiovascular diseases: Position standing in 2022
por: Mahmud, Shabnur, et al.
Publicado: (2022) -
Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges
por: Lei, Xiaotian, et al.
Publicado: (2022) -
Gene editing therapy ready for cardiovascular diseases:
opportunities, challenges, and perspectives
por: Zhou, Jun, et al.
Publicado: (2021)